Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
October 5, 2016
Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis
Georgia Dalagiorgou, Christina Piperi, Christos Adamopoulos, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 6, 2025
SUV39H1 regulates progression of pediatric diffuse high-grade gliomas through modulation of β-catenin/TCF4 levels
Alexia Klonou, Angeliki-Ioanna Giannopoulou, Christos Adamopoulos, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
August 6, 2018
Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis
Antonios N Gargalionis, Lina S Malakou, Christos Adamopoulos, et al.
Cancer Letters
|
June 21, 2020
Polycystin-1 induces activation of the PI3K/AKT/mTOR pathway and promotes angiogenesis in renal cell carcinoma
Antonios N Gargalionis, Eleni Sarlani, Anastasios Stofas, et al.
Histopathology
|
June 14, 2012
Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas
Penelope Korkolopoulou, Georgia Levidou, Elias A El-Habr, et al.
BMC Cancer
|
March 6, 2014
The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma
Anastasios Stofas, Georgia Levidou, Christina Piperi, et al.
Journal of Hematology & Oncology
|
August 17, 2022
Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
Muhammad Elnaggar, Sarita Agte, Paula Restrepo, et al.
Molecular Cancer Research : MCR
|
October 15, 2025
RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors
Beau Baars, Ana Orive-Ramos, Matthew J Emmett, et al.
Plos One
|
January 21, 2015
Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20
Athanasia Sepsa, Georgia Levidou, Antonis Gargalionis, et al.
International Journal of Biological Sciences
|
April 20, 2026
Polycystin-1 Orchestrates Tumor Context-Dependent Mechanotransduction Programs Driving Epithelial-to-Mesenchymal Transition and Invasion in Solid Cancers
Antonios N Gargalionis, Kostas A Papavassiliou, Angeliki-Ioanna Giannopoulou, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Cellular and Molecular Life Sciences : CMLS
|
October 5, 2016
Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis
Georgia Dalagiorgou, Christina Piperi, Christos Adamopoulos, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 6, 2025
SUV39H1 regulates progression of pediatric diffuse high-grade gliomas through modulation of β-catenin/TCF4 levels
Alexia Klonou, Angeliki-Ioanna Giannopoulou, Christos Adamopoulos, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
August 6, 2018
Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis
Antonios N Gargalionis, Lina S Malakou, Christos Adamopoulos, et al.
Cancer Letters
|
June 21, 2020
Polycystin-1 induces activation of the PI3K/AKT/mTOR pathway and promotes angiogenesis in renal cell carcinoma
Antonios N Gargalionis, Eleni Sarlani, Anastasios Stofas, et al.
Histopathology
|
June 14, 2012
Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas
Penelope Korkolopoulou, Georgia Levidou, Elias A El-Habr, et al.
BMC Cancer
|
March 6, 2014
The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma
Anastasios Stofas, Georgia Levidou, Christina Piperi, et al.
Journal of Hematology & Oncology
|
August 17, 2022
Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
Muhammad Elnaggar, Sarita Agte, Paula Restrepo, et al.
Molecular Cancer Research : MCR
|
October 15, 2025
RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors
Beau Baars, Ana Orive-Ramos, Matthew J Emmett, et al.
Plos One
|
January 21, 2015
Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20
Athanasia Sepsa, Georgia Levidou, Antonis Gargalionis, et al.
International Journal of Biological Sciences
|
April 20, 2026
Polycystin-1 Orchestrates Tumor Context-Dependent Mechanotransduction Programs Driving Epithelial-to-Mesenchymal Transition and Invasion in Solid Cancers
Antonios N Gargalionis, Kostas A Papavassiliou, Angeliki-Ioanna Giannopoulou, et al.
Page
of 7